BioPharma Resources

Drug Trial Radar · NCT07518186

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

A Phase 3 Randomized Study Comparing JNJ-79635322 Versus Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma After 1 to 3 Prior Lines of Therapy, Including an Anti-CD38 Antibody and Lenalidomide

Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 700 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

700

Planned (sponsor's estimate)

Start

May 31, 2026

Primary completion

Apr 29, 2029

Study completion Dec 8, 2032

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Apr 8, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate how well JNJ-79635322 works when compared with teclistamab.

Conditions

  • Multiple Myeloma

Interventions

  • JNJ-79635322Drug

    JNJ-79635322 will be administered as SC injection.

  • TeclistamabDrug

    Teclistamab will be administered as SC injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Complete Response (CR) or BetterTime frame: Up to approximately 41 months
  2. Progression-Free Survival (PFS)Time frame: Up to approximately 41 months

Locations

173 sites in 18 countries. Site status is shown where the registry gives one.

  • Alabama Oncology

    Birmingham, Alabama · Recruiting

  • Mayo Clinic 1

    Phoenix, Arizona · Recruiting

  • Highlands Oncology Group

    Springdale, Arkansas · Recruiting

  • Beverly Hills Cancer Center Clinical Research Advisors LLC

    Beverly Hills, California · Recruiting

  • UC Irvine Health Chao Family Comprehensive Cancer Center and Ambulatory Care

    Irvine, California · Recruiting

  • Valkyrie Clinical Trials

    Los Angeles, California · Recruiting

  • University of California Irvine Medical Center

    Orange, California · Recruiting

  • Colorado Blood Cancer Institute

    Denver, Colorado · Recruiting

  • University of Connecticut Health Center

    Farmington, Connecticut · Recruiting

  • Mayo Clinic Jacksonville

    Jacksonville, Florida · Recruiting

  • Memorial Cancer Institute

    Pembroke Pines, Florida · Recruiting

  • Emory University

    Atlanta, Georgia · Recruiting

  • Rush University System for Health

    Chicago, Illinois · Recruiting

  • Franciscan Health

    Indianapolis, Indiana · Recruiting

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa · Recruiting

  • Mission Cancer Blood University of Iowa Health Care

    Waukee, Iowa · Recruiting

  • Norton Cancer Institute

    Louisville, Kentucky · Recruiting

  • LSU Health Feist Weiller Cancer Center

    Shreveport, Louisiana · Recruiting

  • Johns Hopkins Hospital

    Baltimore, Maryland · Recruiting

  • Tufts Medical Center

    Boston, Massachusetts · Recruiting

  • Karmanos Cancer Institute

    Detroit, Michigan · Recruiting

  • University Of Minnesota Medical Center

    Minneapolis, Minnesota · Recruiting

  • Mayo Clinic

    Rochester, Minnesota · Recruiting

  • Nebraska Cancer Specialists

    Omaha, Nebraska · Recruiting

  • Astera Cancer Care

    East Brunswick, New Jersey · Recruiting

  • Christus St. Vincent Regional Cancer Center

    Santa Fe, New Mexico · Recruiting

  • New York Oncology Hematology

    Albany, New York · Recruiting

  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island

    Mineola, New York · Recruiting

  • NYU Langone Health Manhattan

    New York, New York · Recruiting

  • New York Cancer and Blood Specialists

    Shirley, New York · Recruiting

  • Duke University Medical Center

    Durham, North Carolina · Recruiting

  • Gabrail Cancer Center

    Canton, Ohio · Recruiting

  • The Christ Hospital

    Cincinnati, Ohio · Recruiting

  • Dayton Physicians Network Urology

    Dayton, Ohio · Recruiting

  • Willamette Valley Cancer Institute and Research Center

    Eugene, Oregon · Recruiting

  • Bon Secours Saint Francis Cancer Center

    Greenville, South Carolina · Recruiting

  • Tennessee Oncology, PLLC

    Nashville, Tennessee · Recruiting

  • Baylor University Medical Center

    Dallas, Texas · Recruiting

  • Joe Arrington Cancer Research Treatment Center

    Lubbock, Texas · Recruiting

  • Utah Cancer Specialists

    Salt Lake City, Utah · Recruiting

Showing 40 of 173 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.